Suppression of platelet aggregation by Bordetella pertussis adenylate cyclase toxin.

Infect Immun

Department of Bacterial and Blood Products, National Institute of Infectious Diseases, Musashimurayama-shi, Tokyo 208-0011, Japan.

Published: June 1999

The effect of Bordetella pertussis adenylate cyclase toxin (ACT) on platelet aggregation was investigated. This cell-invasive adenylate cyclase completely suppressed ADP (10 microM)-induced aggregation of rabbit platelets at 3 micrograms/ml and strongly suppressed thrombin (0. 2 U/ml)-induced aggregation at 10 micrograms/ml. The suppression was accompanied by marked increase in platelet intracellular cyclic AMP (cAMP) content and was diminished by the anti-ACT monoclonal antibody B7E11. A catalytically inactive point mutant of ACT did not show the suppressive effect. Since an increase of cAMP content is a known cause of platelet dysfunction, these results indicate that the observed platelet inactivation was due to the catalytic activity of ACT through increase of intracellular cAMP.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC96579PMC
http://dx.doi.org/10.1128/IAI.67.6.2763-2768.1999DOI Listing

Publication Analysis

Top Keywords

adenylate cyclase
12
platelet aggregation
8
bordetella pertussis
8
pertussis adenylate
8
cyclase toxin
8
camp content
8
suppression platelet
4
aggregation
4
aggregation bordetella
4
toxin bordetella
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!